DGX

Quest Diagnostics Incorporated

Healthcare
193.16 +0.96 +0.50% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 21.38B
EV —
Shares Out 110.70M
Revenue (ttm) 11.28B
Net Income 1.02B
Beta —
P/E 20.75
Forward P/E —
EPS (ttm) $9.05
P/S 1.88
P/B 2.88
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 6.14%
ROE 14.0%
ROIC 8.89%
Gross Margin —
Oper. Margin 14.27%
Profit Margin 9.08%
Debt/Eq 0.87
LT Debt/Eq 41.17%
Quick Ratio —
Current Ratio 1.18
Book/sh 66.96
Cash/sh 3.57
Div Yield 1.69%
Div TTM $3.26
Payout Ratio 36.02%
SMA20 0.87%
SMA50 -0.54%
SMA200 2.51%
Volume 461,971
Avg Volume 938.92K
Rel Volume —
Perf Week -0.89%
Perf Month 1.22%
Perf Quarter -5.30%
Perf Half Y 5.84%
Perf YTD 11.31%
Perf Year 11.24%
Perf 3Y 43.91%
Perf 5Y 49.88%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.8600
TTM Yield 1.69%
TTM Amount $3.26
Payout Ratio 36.02%
3-Yr Growth (CAGR) 6.62%
5-Yr Growth (CAGR) 7.39%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.8600
Q1 2025 ~2025-12-31 $0.8000
Q3 2025 ~2025-09-30 $0.8000
Q2 2025 ~2025-06-30 $0.8000
Q1 2025 ~2025-03-31 $0.8000
Q1 2024 ~2024-12-31 $0.7500
Q3 2024 ~2024-09-30 $0.7500
Q2 2024 ~2024-06-30 $0.7500
Q1 2024 ~2024-03-31 $0.7500
Q1 2023 ~2023-12-31 $0.7100
Q3 2023 ~2023-09-30 $0.7100
Q2 2023 ~2023-06-30 $0.7100

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Quest Diagnostics works across the healthcare ecosystem to create a healthier world by providing diagnostic insights from clinical laboratory testing results that empower people, physicians, and organizations to take action to improve health outcomes. The company's services derive from one of the world's largest databases of de-identifiable clinical lab results. The company serves approximately one-third of the adult U.S. population annually and approximately one-half over a three-year period, with approximately half of U.S. physicians and half of U.S. hospitals as customers. Quest Diagnostics offers an industry-leading menu of routine and advanced diagnostic testing services, including molecular diagnostics, oncology, neurology, companion diagnostics, and non-invasive genetic testing. Key offerings include reference testing for hospitals, collaborative lab solutions supporting hospital lab operations, and consumer-initiated services through QuestHealth.com. The company generated net revenues of $11.0 billion in 2025 and operates approximately 2,400 patient service centers, many located in retail settings. Quest Diagnostics serves customers including physicians, hospitals, patients and consumers, health plans, employers, government agencies, pharmaceutical companies, and commercial clinical laboratories. The company is headquartered in Secaucus, New Jersey, and was incorporated in Delaware in 1990.

Name
Quest Diagnostics Incorporated
Industry
Diagnostics & Research
CEO
James E. Davis · Chairman, Chief Executive Officer and President
Employees
175 as of 2025-12-31
IPO Date
2016-04-07
Phone
(973) 520-2700
Address
500 Plaza Drive, Secaucus, NJ 07094
Website
www.QuestDiagnostics.com

Key Executives

Name Title FY Pay
Cathy Doherty Chief Financial Officer —
James E. Davis Chairman, Chief Executive Officer and President —

Latest News